Table 3.

Mortality data of study population by treatment allocation.

	Control N=139	LPV/r N=139	Difference	Adj.p (vs. control)	DRV/r N=139	Difference	Adj.p (vs. control)	LPV/r vs. DRV/r difference	Adj.p LPV/r vs. DRV/r
Days spent in hospital	8.09 ± 6.0	10.63 ± 5.5	-2.54 (-4.24 to -0.83)	<0.001	12.83 ± 6.4	-4.73(-6.42 to -3.044)	<0.001	-2.193 (-3.89 to -0.48)	0.007
Time to clinical improvement (average days ± SD)	7.9 ± 5.9	10.6 ± 5.4	-2.69 (-4.41 to -0.97)	<0.001	11 ± 6.3	-3.13 (-4.87 to -1.37)	<0.001	-0.43 (-2.16 to 1.30)	0.82
In-hospital mortality	10 (7.2%)	5 (3.6%)		0.09	14 (10%)		0.19		0.016
Time to death	10.1 ± 6.7	13.8 ± 8.4	-3.7 (-13.68 to 6.27	0.63	13.4 ± 7.1	-3.32 (-10.87 to 4.21)	0.52	0.37 (-9.11 to 9.8)	0.99
Univariate analysis (HR, 95% CI)	–	0.39 (0.19-0.99)	–	0.04	1.49 (0.71-3.12)	–	0.28

Data is expressed as mean ± SD. CI, confidence interval; HR, hazard ratio.